The global microRNA (miRNA) market size is expected to reach USD 458.0 Million by 2028 at a CAGR of 11.6%, according to a new report by Reports and Data. Significant revenue growth is mainly attributed to increasing research & development programs on genomics and RNA biology, rise in adoption of high-throughput miRNA analysis techniques, and emergence of next-generation miRNA sequencing techniques. Rising prevalence of chronic disorders such as cancer, increasing infectious disease outbreaks such as the ongoing COVID-19 pandemic, and growing applications of miRNA in the pharmaceutical and biotechnology sectors are other key factors responsible for market growth. Furthermore, major advancements in gene sequencing technologies and rise in government investments in life sciences R&D activities bolster the global microRNA (miRNA) market growth.
A microRNA (miRNA) is a small, single-stranded RNA molecule present in animals, plants, and different viruses. Post-transcriptional regulation of gene expression and RNA silencing are two of the key functional areas of miRNAs. miRNAs complement messenger RNA (mRNA) in down-regulating the gene expression and also regulate several vital cellular functions such as cell differentiation, proliferation, and apoptosis. Besides identifying different cell types, they play an indispensable role in cell physiology and development and various pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. miRNAs are present in various mammalian cell types in large numbers. MicroRNA sequencing is a form of RNA sequencing that involves next-generation DNA sequencing technology and is performed by researchers to study miRNA isoforms, tissue-specific expression patterns, and disease associations.
Some Key Highlights in the Report:
- Based on product type, the kits, reagents, and consumables segment emerged as the most dominant segment in 2020, with the highest revenue share of over 60%. Growth of this segment can be attributed to extensive use of detection kits, consumables, qPCR primers, and transfection reagents miRNA profiling and analysis due to their non-durable nature.
- The RT-PCR research tools segment was the most dominant in 2020 and accounted for a revenue share of around 33% in the global microRNA (miRNA) market. High reliability and sequence specificity of this technique for detection of miRNA expression, increasing applications of RT-PCR in miRNA profiling, quantitation, validation, and analysis, and rapidly increasing volumes of RT-PCR tests for COVID-19 are the key factors driving the growth of this segment.
- North America accounted for the highest revenue share of around 45% in the global microRNA (miRNA) market in 2020. Market growth in this region is accelerated by increasing research & development activities in the fields of genomics, proteomics, and oncology, introduction of advanced miRNA biomarkers, increasing R&D investments in the biotechnology and biopharmaceutical industries, and the state-of-the-art healthcare infrastructure in North America.
Competitive Landscape:
The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, product & service portfolio. The MicroRNA (miRNA) market is extremely competitive and consists of several key players at regional and global level. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures and collaborations to strengthen their market position and enhance product portfolio.
Leading companies operating in the market are:
Agilent Technologies, Exigon, Merck KGA, Illumina, Inc., NanoString Technologies, Inc., and Thermo Fischer Scientific
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/sample-enquiry-form/1418
The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:
MicroRNA (miRNA) Market Segmentation:
Product Type Outlook (Revenue, USD Million; 2020-2028)
- Instruments
- Kits, Reagents, and Consumables
- Isolation & Purification
- Quantification & Detection
- Functional Analysis
- Others
Research Tools and Services Outlook (Revenue, USD Million; 2020-2028)
- Tools
- RT-PCR
- Biomarkers
- Next Gen Sequencing (NGS)
- Microarray Analysis Tools
- Functional Analysis Tools
- Extraction Tools
- Others
- Services
- miRNA cDNA Synthesis
- Quantification Services
- Microarray Services
- Sequencing Services
- Functional Studies Services
- Others
Application Outlook (Revenue, USD Million; 2020-2028)
- Cancer
- Infectious Diseases
- Immunological Disorder
- Cardiovascular Disease
- Neurological Disease
- Others
Geographic Segment Covered in the Report:
The MicroRNA (miRNA) report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.
• North America (the USA and Canada)
• Europe (UK, Germany, France, and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• the Middle East and Africa (GCC and the rest of the Middle East and Africa)
Key market aspects are illuminated in the report:
- Executive Summary: It covers a summary of the most vital studies, the Global MicroRNA (miRNA) market increasing rate, modest circumstances, market trends, drivers and problems as well as macroscopic pointers.
- Study Analysis: Covers major companies, vital market segments, the scope of the products offered in the Global MicroRNA (miRNA) market, the years measured, and the study points.
- Company Profile: Each Firm well-defined in this segment is screened based on a products, value, SWOT analysis, their ability and other significant features.
- Manufacture by Region: This Global MicroRNA (miRNA) report offers data on imports and exports, sales, production and key companies in all studied regional markets.
Thank you for reading the report. Kindly note that we also offer customized reports according to the client’s requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.
Explore More Industry Research by Reports and Data:
Latex Tourniquet Market @ https://www.reportsanddata.com/report-detail/latex-tourniquet-market
DNA Vaccination Market @ https://www.reportsanddata.com/report-detail/dna-vaccination-market
Plasma Fractionation Market @ https://www.reportsanddata.com/report-detail/plasma-fractionation-market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States
Website: https://www.reportsanddata.com/report-detail/microrna-mirna-market